Moving forward with technology adoption and ramped – Up manufacturing

Evidently, innovations happen at a time when humanity is in dire need of one. The COVID-19 pandemic has proved this to be true once again taking into consideration the pace at which vaccines were developed, and rolled out; in less than 15 months from the time COVID-19 was declared a pandemic by WHO.

HiMedia as an organization has always been at the forefront when it comes to rolling out products after extensive research and development. The robust team of exceptionally talented scientists and technical experts keep themselves updated on current and future trends through online as well as offline literature resources like PubMed, Google Scholar, Research Gate, and various patent sites.

Being the only company of Indian origin listed among the top 5 multinationals within Biotech Suppliers space, we relentlessly strive to maintain that locus at the global front.

Getting ahead with brand HiMedia
Talking about our microbiology division, the portfolio has been further expanded by developing an entire range of ready-prepared media. We have developed a complete line of animal free culture media and ingredients under the brand of HiVeg. Today HiVeg products are used by many biopharmaceutical and vaccine manufacturers worldwide. Through government funding and collabo­ration with premier institutes, we are working toward developing the process of manufacture of gellan gum and agar.

As anticipation of the biosimilars sector to boom at a CAGR of 30–35 percent became more apparent, our animal cell culture division has set up a world-class upstream media development and bioprocess optimization lab. Setting up an advanced analytical characterization lab for mAbs (monoclonal antibodies) and other therapeutic proteins, manufacturing media for biotherapeutic pro­tein production in their world-class cGMP facilities, in very large volumes, with single lot sizes of 5000 kg are listed in the future endeavors of HiMedia.

Additionally, we are working on developing media for the storage and transportation of organs as well as a broad range of products to support the stem cell and gene therapy industry. HiMedia as a brand will be a part of one of the largest in India and top media manufacturers in the world.

Through our molecular biology division, which goes by the name HigenoMB®, we plan to unravel the untouched space of intuitive medicine by means of PCR based detection of anti- microbial markers to help in drug of choice decisions to the clinician. We also prepare to expand our presence on the grassroots level by point-of-care testing platforms, thus helping in fostering a better healthcare infrastructure for the country.

Enhancing the biostatistics space for sequencing and post sequencing gene mapping analysis and moving profoundly on the transcriptional studies of key proteins is what we look forward to.

Our hydroponics business division, named as Higronics® is set to lead the home and urban farming space in metros and help farmers take up vertical farming and enhance earnings by increased harvest capacity. Being pioneers into providing turnkey solutions within hydroponics, we focus on innovation and technology in formulating crop specific hydroponics nutrition solutions that would help solve food crisis through soil-less farming.

Shift in marketing dictums
The industrial landscape for biopharmaceutical being diverse, we have maintained our focus on multiple investment and development strategies rather than focusing on single strategy.

Collaboration with institutes or companies for research, development, manufacture, and marketing of products is the new area HiMedia has been exploring.

The rapidly changing market and customer expectations have led us to change our stance on conventional marketing dictums and shift toward owning the digital landscape. We are developing multi-country website on the latest magento platform thus, reaching to a hi-tech level. Having expertise in IT services, our team tries to provide seamless services to the entire organization without any manual intervention.